eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
NOWOŚĆ
Portal dla gastroenterologów!
www.egastroenterologia.pl
SCImago Journal & Country Rank
3/2024
vol. 19
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Artykuł oryginalny

The effects of hyperbaric treatment on perianal fistula activity in patients with Crohn’s disease

Grażyna Piotrowicz
1
,
Jacek Kot
2, 3
,
Andrzej Babicki
4
,
Piotr Banaszkiewicz
1
,
Adam Piotrowicz
4
,
Magdalena Rzeszutek
1
,
Agata Rudnik
1, 5
,
Piotr Zientara
6
,
Joanna Adamska-Mieruszewska
6
,
Grażyna Rydzewska
7, 8

  1. Department of Gastroenterology, Self-Dependent Health Care Unit of Ministry of Interior and Administration, Gdansk, Poland
  2. National Centre for Hyperbaric Medicine Institute of Maritime and Tropical Medicine in Gdynia, Medical University of Gdansk, Poland
  3. Department of Hyperbaric Medicine and Sea Rescue, University Centre for Maritime and Tropical Medicine, Gdynia, Poland
  4. Department of Surgery, Self-Dependent Health Care Unit of Ministry of Interior and Administration, Gdansk, Poland
  5. Institute of Psychology, University of Gdansk, Gdansk, Poland
  6. Faculty of Economics, University of Gdansk, Gdansk, Poland
  7. Department of Internal Medicine and Gastroenterology, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland
  8. Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Data publikacji online: 2024/09/27
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Introduction:
Crohn’s disease is a chronic, complex inflammatory disorder of the gastrointestinal tract. Among its most challenging complications are perianal fistulas.

Aim:
This study aims to explore the efficacy of hyperbaric oxygen therapy (HBOT) in reducing the activity of perianal fistulas in Crohn’s disease patients.

Material and methods:
This study enrolled patients diagnosed with Crohn’s disease-associated perianal fistulas, with a disease duration of at least 3 years. Participants underwent HBOT in conjunction with standard medical therapy. The therapeutic effects were assessed at predetermined intervals using the Crohn’s Disease Activity Index (CDAI), and laboratory parameters including faecal calprotectin levels, C-reactive protein (CRP) activity, serum iron concentration, and peripheral blood haemoglobin levels. Additionally, the Simple Endoscopic Score for Crohn’s Disease (SESCD) and the Perianal Disease Activity Index (PDAI) were employed for evaluation.

Results:
The adjunctive use of HBOT with conventional therapy yielded significant clinical improvements in patients with Crohn’s disease complicated by perianal fistulas. This was shown by an 81.8% improvement in CDAI scores and a 54.5% clinical remission rate, as determined by SESCD and PDAI. Notably, the beneficial effects of HBOT on SESCD, PDAI, and faecal calprotectin levels were statistically significant and persisted for 6 weeks post-HBOT, with sustained improvements observed in a follow-up assessment approximately 9 months after treatment.

Conclusions:
The findings of this study suggest that HBOT may be a viable therapeutic adjunct in the management of complex cases of Crohn’s disease, particularly those with recurrent symptoms and limited responsiveness to conventional treatments. HBOT demonstrated potential in improving clinical outcomes and achieving remission rates exceeding 50%, indicating its promise as a treatment modality in this patient population.

© 2024 Termedia Sp. z o.o.
Developed by Bentus.